Prevalence of multidrug resistance bacterial isolates from infected wound patients in Dhaka, Bangladesh: A cross-sectional study

被引:20
作者
Alam, Mohammad Morshad [1 ,2 ]
Islam, Md Nazrul [3 ]
Hawlader, Mohammad Delwer Hossain [2 ]
Ahmed, Shakil [2 ]
Wahab, Abrar [2 ]
Islam, Muzahidul [4 ]
Uddin, K. M. Roshed [5 ]
Hossain, Ahmed [2 ]
机构
[1] World Bank, Hlth Nutr & Populat Global Practice, Dhaka, Bangladesh
[2] North South Univ, Dept Publ Hlth, Dhaka 1229, Bangladesh
[3] Medinova Med Serv LTD, Dept Microbiol, Dhaka 1209, Bangladesh
[4] Noakhali Sci & Technol Univ, Dept Microbiol, Noakhali, Bangladesh
[5] Sapienza Univ Rome, Fac Econ, Rome, Italy
关键词
AMR; MDR; Wound infection; Bacteria; Dhaka; ANTIMICROBIAL RESISTANCE; STAPHYLOCOCCUS-AUREUS; SUSCEPTIBILITY;
D O I
10.1016/j.ijso.2020.12.010
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Introduction: Multidrug resistance (MDR) is threatening the adequate coverage of antibiotics. This study aimed to analyze the antimicrobial resistance pattern of bacterial isolates from wound infection and the scenario of multidrug resistance. Methods: Microbiological culture results scripts of Medinova Medical Services LTD, representing non-repetitive various wound samples (post-surgical, trauma, superficial skin, burn) reported between January 2017 and March 2018, were retrieved and analyzed for pathogens and their antimicrobial resistance patterns using R version 3.5.3. Results: Overall, 1266 bacterial isolates were obtained, and 850 (67.1%) were identified as MDR. The percentage of MDR among gram-positive and gram-negative bacterial isolates were 68.8% and 66.0%, respectively. Among isolates Staphylococcus aureus (n = 401), Pseudomonas aeruginosa (n = 200), and Escherichia coli (n = 193) were predominant. Vancomycin followed linezolid showed most activity against gram-positive bacteria. Whereas, Colistin was found to be the most active against most of the gram-negative bacterium except for the Proteus spp in sensitivity test. Although, carbapenem group was determined to be the best against Proteus spp. About 82% Enterococcus spp and 76% Proteus spp were MDR. Isolates from patients aged >60 years (AOR = 1.774 95%CI: 1.089-2.892) were more prone to becoming MDR in compared to other age group and was a significant determinant (P = 0.02) of MDR. Conclusions: Our study revealed that the presence of MDR pathogens in wound infection was noteworthy. The findings of this study would assist in decision making of wound infection treatment. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of Surgical Associates Ltd.
引用
收藏
页码:56 / 62
页数:7
相关论文
共 36 条
[21]  
Macdonald G, 2008, INTERN MED J, V38, P932, DOI [10.1111/j.1445-5994.2008.01837.x, DOI 10.1111/J.1445-5994.2008.01837.X]
[22]   The growing challenges of antibacterial drug resistance in Ethiopia [J].
Moges, Feleke ;
Endris, Mengistu ;
Mulu, Andargachew ;
Tessema, Belay ;
Belyhun, Yeshambel ;
Shiferaw, Yitayal ;
Huruy, Kahsay ;
Unakal, Chandrashekhar ;
Kassu, Afework .
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2014, 2 (03) :148-154
[23]   Non-prescription antimicrobial use worldwide: a systematic review [J].
Morgan, Daniel J. ;
Okeke, Iruka N. ;
Laxminarayan, Ramanan ;
Perencevich, Eli N. ;
Weisenberg, Scott .
LANCET INFECTIOUS DISEASES, 2011, 11 (09) :692-701
[24]   Colonization with Multidrug-Resistant Gram-Negative Bacteria: Prolonged Duration and Frequent Cocolonization [J].
O'Fallon, Erin ;
Gautam, Shiva ;
D'Agata, Erika M. C. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (10) :1375-1381
[25]  
Ohalete CNORK, 2012, BACTERIOLOGY DIFFERE, P1155
[26]   A step closer to extreme drug resistance (XDR) in gram-negative bacilli [J].
Paterson, David L. ;
Doi, Yohei .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (09) :1179-1181
[27]   Prevalence of multidrug-resistant, methicillin-resistant Staphylococcus aureus in the United States:: findings of the stratified analysis of the 2004 to 2005 LEADER Surveillance Programs [J].
Pillar, Chris M. ;
Draghi, Deborah C. ;
Sheehan, Daniel J. ;
Sahm, Daniel F. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2008, 60 (02) :221-224
[28]  
Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007
[29]   Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review [J].
Sakeena, M. H. F. ;
Bennett, Alexandra A. ;
McLachlan, Andrew J. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (06) :771-782
[30]  
Sani R.A., 2012, J HLTH SCI, V2, P19